HIGHLIGHTS
- who: Jasmin Galper et al. from the Charles Perkins Centre and Faculty of Medicine and Health, School of Medical Sciences, University of Sydney have published the research: LRRK2 and Lipid Pathways: Implications for Parkinsonu2019s Disease, in the Journal: Biomolecules 2022, 1597 of /2022/
- what: Critically, this study demonstrated that in contrast to the total level of each lipid class changing in serum from LRRK2 G2019S carriers, different lipid species within each of these lipid classes were significantly altered in opposing directions of change .
- future: Studies are needed to confirm the report of decreased . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.